CD8A and neoplasm: The observed early decrease in tumor-associated macrophages and subsequent increase in CD8+ T-cell infiltration at the optimal dose highlights the dynamic interplay between histotripsy treatment parameters and the tumor immune microenvironment at various timepoints.